Evaluating the Gynecare TVT ABBREVO® Continence System for treating urinary incontinence in women
Official title: A Long Term Prospective Post Market Clinical Follow-up (PMCF) of the GYNECARE TVT ABBREVO® Continence System for the Treatment of Stress Urinary Incontinence
Run by Ethicon, Inc. · NCT04829357 · Data updated 2026-11-12
This study is testing the Gynecare TVT ABBREVO® system to see if it helps women with stress urinary incontinence feel better after surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years and up |
| Sex | Women only |
| Enrollment | 195 (estimated) |
| Sponsor | Ethicon, Inc. Industry-sponsored |
| Locations | 4 sites (North Wales, Pennsylvania and 3 other locations) |
| Status | Recruiting |
| Started | September 9, 2021 |
| Main results expected | December 31, 2033 |
| Study ends | December 31, 2038 |
| Registry record updated | July 6, 2026 |
| Trial ID | NCT04829357 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 21 and older who have been diagnosed with stress urinary incontinence and are planning to undergo mid-urethral sling surgery.
✕Probably not a fit
Patients with physical or psychological conditions that impair their ability to participate in the study or complete required assessments will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the performance of the Gynecare TVT ABBREVO® Continence System in women who are undergoing mid-urethral sling surgery for stress urinary incontinence (SUI). It involves a single-arm approach where eligible participants will be monitored post-surgery to evaluate the effectiveness of the continence system. The study will include women aged 21 and older who have been diagnosed with SUI and are planning to undergo surgical treatment without additional prolapse surgery. Participants will be required to provide informed consent and participate in follow-up assessments.
Why it matters
Potential benefit: If successful, this study could improve treatment options for women suffering from stress urinary incontinence.
How similar studies have gone: Other studies on mid-urethral sling systems have shown promising results, indicating that this approach is supported by prior research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Subjects who satisfy all of the following criteria will be considered eligible for enrollment in this study: 1. Stress urinary incontinence symptoms 2. Diagnostic evaluation, a positive cough stress rest, to confirm diagnosis of stress urinary incontinence. 3. Female subjects ≥ 21 years of age requiring treatment of SUI 4. Desired surgical correction of stress urinary incontinence using synthetic sub-urethral vaginal slings 5. Planned surgery for primary stress incontinence without concomitant prolapse surgery 6. Patient able and willing to participate in follow-up 7. Subject or authorized representative has signed the approved informed consent Exclusion Criteria Subjects meeting any of the following criteria will be considered not eligible for enrollment in this study: 1. Physical or psychological condition which would impair study participation or are unwilling or unable to participate in all required study visits and are unable to complete the questionnaires 2. Any pre-operative or intra-operative findings identified by the surgeon that may preclude the use of study product 3. History of previous synthetic, biologic or fascial sub-urethral sling 4. Pregnancy or plans for future pregnancy 5. History of bleeding diathesis or current anti-coagulation therapy which cannot be suspended peri-operatively according to site's standard practice. 6. Current genitourinary fistula or urethral diverticulum 7. Reversible cause of incontinence (i.e. drug effect) 8. Contraindication to surgery
Where it's running
-
Institute for Female Pelvic Medicine
North Wales, Pennsylvania, United States Recruiting -
Bio-Medical University Rome
Rome, Italy Recruiting -
Ospedale San Pietro Fatebenefratelli
Rome, Italy Recruiting -
Ospedale Regionale Beata Vergine
Mendrisio, Switzerland Recruiting
Study contacts
- Study coordinator: Christine Romanowski
- Email: cromanow@its.jnj.com
- Phone: 908-808-6219
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if increasing running cadence helps stress urinary incontinence in parous runners
This study tests whether increasing running cadence by about 10% for eight weeks can reduce stress urinary incontinence symptoms in parous women who run regularly and own a Garmin watch.
-
Prophylactic antibiotics to reduce post-procedure UTIs after urethral bulking
We’re testing whether giving a preventive antibiotic at the time of urethral bulking can lower the chance of a urinary tract infection after the procedure for women with stress or mixed urinary incontinence.
-
Evaluating the impact of different mesh widths in surgery for urinary incontinence
This study is testing whether using a wider surgical mesh during surgery for urinary incontinence in women can lead to better results and fewer problems.
-
Evaluating postoperative activity restrictions after midurethral sling placement
This study is testing whether patients who have had a midurethral sling procedure for stress urinary incontinence do better with strict activity limits or no limits after surgery.
-
Comparing two procedures for treating stress urinary incontinence during vaginal prolapse repair
This study is testing whether a new type of surgery or an injection is better for helping women with stress urinary incontinence during vaginal prolapse repair.
-
Effectiveness and safety of shorter tapes for urinary incontinence
This study looks at whether shorter surgical tapes for treating urinary incontinence in women can improve their quality of life and have fewer complications compared to longer tapes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.